REPH
NASDAQRecro Pharma Inc.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)SC 13G/A - Societal CDMO, Inc. (0001588972) (Subject)
- 13D/GSEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)SC 13G/A - Societal CDMO, Inc. (0001588972) (Subject)
- INSIDERLake Ryan David covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 0.13% to 800,557 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDEREnloe J David Jr was granted 196,474 shares, increasing direct ownership by 18% to 1,295,414 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David was granted 110,025 shares and covered exercise/tax liability with 37,453 shares, increasing direct ownership by 10% to 801,579 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David covered exercise/tax liability with 34,096 shares, decreasing direct ownership by 4% to 729,007 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David covered exercise/tax liability with 1,419 shares, decreasing direct ownership by 0.19% to 763,103 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David covered exercise/tax liability with 5,690 shares, decreasing direct ownership by 0.74% to 764,522 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.16% to 770,212 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- SECRecro Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Societal CDMO, Inc. (0001588972) (Filer)
- SECSEC Form 10-Q filed by Recro Pharma Inc.10-Q - Societal CDMO, Inc. (0001588972) (Filer)
- SECRecro Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Societal CDMO, Inc. (0001588972) (Filer)
- INSIDERLake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.16% to 771,409 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERLake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.15% to 772,607 units (SEC Form 4)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- SECRecro Pharma Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Societal CDMO, Inc. (0001588972) (Filer)
- INSIDERSEC Form 4: Lake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.15% to 773,805 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- 13D/GSEC Form SC 13G filed by Recro Pharma Inc.SC 13G - Societal CDMO, Inc. (0001588972) (Subject)
- INSIDERSEC Form 4: Ashton William bought $10,111 worth of shares (22,222 units at $0.46), increasing direct ownership by 9% to 263,622 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Reasons Bryan M. bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 27% to 291,049 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Weisman Wayne bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 25% to 308,602 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Miller James Charles bought $15,000 worth of shares (37,500 units at $0.40), increasing direct ownership by 20% to 227,543 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Cant Elena bought $12,000 worth of shares (30,000 units at $0.40), increasing direct ownership by 41% to 103,620 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Churchill Winston J bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 26% to 301,602 units4 - Societal CDMO, Inc. (0001588972) (Issuer)
- INSIDERSEC Form 4: Awm Investment Company, Inc. bought $56,000 worth of shares (140,000 units at $0.40)4 - Societal CDMO, Inc. (0001588972) (Issuer)
- SECSEC Form 424B5 filed by Recro Pharma Inc.424B5 - Societal CDMO, Inc. (0001588972) (Filer)
REPH FAQ
7 questionsWhat does Recro Pharma Inc. do?
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.Where does REPH stock trade?
Recro Pharma Inc. (REPH) is listed on NASDAQ.What sector and industry is REPH in?
Recro Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Recro Pharma Inc. go public?
Recro Pharma Inc. (REPH) completed its IPO in 2014.What are analysts saying about REPH?
Recro Pharma Inc. has had 1 recent analyst action on file. The most recent action was from William Blair: Outperform on 2021-10-12.What companies are similar to REPH?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare REPH side-by-side with any of them on Quantisnow.How can I track REPH on Quantisnow?
Quantisnow aggregates Recro Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow REPH to receive live email and push alerts on every new disclosure.